CULLINAN ONCOLOGY INC
CULLINAN ONCOLOGY INC
Share · US2300311063 · CGEM (XNAS)
Overview Financial Indicators
9,08 USD
6,57 % 0,56 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 20:00

Current Prices from CULLINAN ONCOLOGY INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
CGEM
USD
06.06.2025 20:00
9,08 USD
8,75 USD
+3,83 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,89 % 15,67 % 6,70 % -30,47 % -59,72 % -69,64 %

Company Profile for CULLINAN ONCOLOGY INC Share

Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Oncology, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Company Data

Name CULLINAN ONCOLOGY INC
Company Cullinan Oncology, Inc.
Symbol CGEM
Website https://www.cullinanoncology.com
Primary Exchange XNAS NASDAQ
ISIN US2300311063
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Nadim Ahmed
Market Capitalization 453 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address One Main Street, 02142 Cambridge
IPO Date 2021-01-08

Ticker Symbols

Name Symbol
NASDAQ CGEM

More Shares

Investors who CULLINAN ONCOLOGY INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
APPLIED MATERIALS INC
APPLIED MATERIALS INC Share
AUTODESK INC
AUTODESK INC Share
BNPP EURO MID CAP CCL
BNPP EURO MID CAP CCL Fund
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
ClimateRock - Class A Ordinary Shares
ClimateRock - Class A Ordinary Shares Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
INTEL CORP
INTEL CORP Share
INTUIT INC
INTUIT INC Share
ISHSV IBD26TEOC EOD
ISHSV IBD26TEOC EOD ETF
MICROSOFT CORP
MICROSOFT CORP Share
MONSTER BEVERAGE CORP
MONSTER BEVERAGE CORP Share
WACKER NEUSON SE
WACKER NEUSON SE Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025